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This study assessedpatients ‘knowledge, experience and satisfac
tion with their cancer pain management, explored professional
documentation and assessment practices and the presence or
absence of institutional infrastructures that support path manage
ment. The findings were then compared to the recommended
standards and guideihes published by the World Health Organiza
tion, American Pain Society and Agency for Health Care Policy and
Research.
Introduction
It is well documented that approximately 85% of patients with
cancer experience pain during the course of their illness or treat
ment.”2 The literature also suggests that only 70% of all cancer
patients experiencing pain feel that their pain management is effec
tive.3 Studies of pain and patient satisfaction find that patients often
rate their satisfaction high even when pain is severe, “suggesting that
patients do not expect consistent pain relief and that the use of patient
satisfaction questions without other questions about pain ratings
may overlook suboptimal pain relief.” Hill states that although
appropriate opioid analgesics and knowledge about pain is wide
spread, cancer pain is still widely uncontrolled.4Portenoy believes
that undertreatment by practitioners is the primary reason for unre
lieved cancer pain although 70% to 90% of this pain can be relieved
through pharmacological methods alone.5The World Health Orga
nization (WHO) devised an analgesic “ladder” approach to cancer
pain management based on “the premise that most patients.. should
have adequate pain relief if health care providers learn how to use a
few effective and relatively inexpensive drugs well and administer
them. ..according to the individual needs of the patient.”6 It is
estimated that the use of the “three step ladder” devised by the WHO
for use in controlling cancer pain effectively controls pain in 71%-
97% ofpatients.7However, with the increasing number of adjuvants
and analgesics available for use in different strengths and by
different routes, factors such as cost, equianalgesia and patient
preferences must be considered when defining a pain treatment plan.
Assessment and documentation are essential for successful pain
management, providing the baseline data from which prescribing
and treatment decisions are made. The AHCPR Clinical Practice
Guidelines forManagement ofCancer Pain state that “pain manage
ment should be evaluated at points of transition in the provision of
services to ensure that optimal pain management is achieved and
maintained.”2The APS suggests that standardized assessment and
communication is the key to successful pain management.6Gather
ing data and documenting the current status of pain management are
important prerequisites to implementing change. Recent studies
show that nurses do not always document patient and family
teaching or follow the nursing process which requires assessment
and ongoing evaluation of patient care and goals.’2A recent study in
Holland of the effects of a continuing education program on nurses’
practice in taking pain histories, performing assessments and man
aging pain showed an increase in the quality of these activities but
not in related quantitative activities such as use ofpain rating scales.
The nurses participating in the study attributed this phenomena to a
lack of support from physicians, varied prescriptive practices, a lack
of administrative policies supporting a change in practice and their
own reluctance to change their daily routine.’3 For cancer pain
management to become an integrated standard of practice “the
challenge of implementation requires involvement by many indi
viduals within the institution.”8Since the majority ofcancerpatients
in Hawaii receive their primary and secondary treatment in Hono
lulu, the importance of standardizing education, assessment and
documentation cannot be underestimated.
The research questions this study addressed include:
I) Is there a significant relationship between patients’ level of
comfort, knowledge about and satisfaction with their pain
control?
2) Is the WHO Analgesic ladder in widespread use?
3) Are the recommendations from the AHCPR and APS guide
lines for assessment and documentation reflected in current
procedures, policies and practices?
Methodology
This study was conducted over a one-year period in seven major
medical centers on the island of Oahu. The Institutional Review
Board of each medical center approved the study. Primary data was
gathered using a patient questionnaire, chart review and an institu
tional audit tool. The questionnaires were systematic adaptations of
tools from the City ofHope Medical Center and used an analog scale
to assess patients’ level ofpain or agreement or disagreement (0-10;
0 = disagree, 10 = agree) with professional beliefs about cancer pain
and its management. Each co-investigator was trained in the use of
the tools, in assessing a patient’s ability to use the questionnaire and
in obtaining a signed consent to participate. Each questionnaire took
approximately 15 minutes to complete. Any patient concerns or
questions about pain that arose as a result of this study were reported
to the participant’s physician.
The chart review tool was also a systematic adaptation of the tool
used by the City of Hope Medical Center. This tool was used on the
day the questionnaire was administered to evaluate the types and
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methods of assessment and documentation that were being used by
various professionals and to record the medications that were
currently ordered and being used by each patient. The institutional
audit form was also a replication of the tool used at the City of Hope
Medical Center. It was used only once in each setting to determine
if policies, procedures and institutional processes were in place to
insure quality pain management.
Inclusion in the non-random sample required participants to speak
English, have a primary diagnosis ofcancer and they must have been
on at least one opioid for non-surgical, cancer-related pain. Due to
reorganization of the oncology units in two of the medical centers
and a large population of patients who were non-English speaking
or unable to participate due to their physical condition, the study
failed to meet the expected sample size of 20 patients per medical
center. However, a total of 100 attempts were made, 69 surveys were
collected and 67 were usable.
Results: Survey and Chart Review
There were thirty-six (36) males and thirty-three (33) females
surveyed. While most respondents were between the ages of 40 and
80, three participants were under 30 and two were over 80.
Figure 1 illustrates the ethnicity of the respondents. Other data
includes when the participants were diagnosed and when their pain
began. Table 1 illustrates this information.
Participants were asked to fill out a survey that rated their
experience with pain over the last week, the last twenty-four hours
and at the time of the survey. Respondents diagnoses and the
responses to the pain experience questions are illustrated in Figures
2, 3,4 and 5. All but six of the participants were outpatients during
the week prior to the survey. Twelve patients (17%) were receiving
radiation therapy, 29 patients (43%) were receiving chemotherapy
and 41 patients (39%) were receiving no active cancer treatment.
Patients were also asked to rate any side effects of opioid analgesics
that they might be experiencing such as nausea, constipation and/or
drowsiness. Analog scales were used for all of the ratings (0=none;
10=worst possible). Table 2 illustrates the responses to these ques
tions.
Patients’ knowledge and beliefs about cancer pain and its man
agement were also assessed to see if they agree with current beliefs
among health care professionals about cancer pain and its manage
ment. Participants were asked to respond using a 0-10 analog scale
(0=disagree; 10=agree) to statements professionals generally be
lieve to be true. The responses, showing patients’ agreement or
disagreement with these statements, are illustrated in Table 3.
A concurrent chart review was performed for each respondent to
look for the absence or presence of practices that adhere to estab
lished standards or guidelines. The chart review specifically looked
for consistent use of a pain rating scale, consistent assessment,
documentation and prescriptive practices during the time period of
the survey, i.e., the twenty-four hours during which the survey was
given to the patient to complete. Subjective descriptions of pain,
such as, “I feel better today” or “patient states pain continues”, were
found in 41 respondents’ charts. Objective descriptions, specifically
analog pain ratings, were found in 50 of the charts reviewed (n = 67).
As Figure 6 illustrates, assessment and documentation of pain
ratings vary widely between disciplines and within the patient’s
record.
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Table 2.—Respondents’ Experience with Side Effects
* Rating scale: 0-3 4-6 7-10
No. of patients
Do you have a problem
with constipation? 36 13 14
Do you have a problem
with nausea2 45 11 9
Do you have a problem with
drowsiness from your medications? 37 20 9
* O-3=none to mild; 4-6=moderate; 7-1 0=severe
Table 3.—Respondents’ Knowledge and Beliefs Regarding Pain
and Pain Control
Table 1.—Length of Time Participants Experienced Cancer and Pain
When was your cancer diagnosed? When did your pain begin?
No. ots/% No. pts/%
a) in last week 3 (4.7%) a) in last week 2 (3.3%)
b) in last month 5 (8%) b) in the last month .... 7 (11%)
c) in last 6 mos 20 (30%) C) in last six months 25 (39%)
d) 6- 12 mos. ago 9 (13%) d) 6-12 months 12 (18%)
e) 1-2 years ago 5 (8%) e) 1-2 years ago 0
1) 2-3 years ago 7 (11%) f) 2-3 years ago 3 (4.7%)
g) 3-5 years ago 8 (12%) g) 3-5 years ago 6 (9%)
h) >5 years ago 6 (9.5%) h) >5 years ago 4 (6%)
Four surveys were unanswered
Knowledge Statements








Cancer pain medicines should be
taken before pain becomes severe 8
It is alright to take more than one
type of pain medicine 9
9 49
It is better to take pain medicine
around the clock rather than
only when needed. (3 unanswered) 16
19 25
Are you satisfied with the




Table 4.—Number of OpioidslAdjuvants and Routes of Administration twenty-four hours?” and “How much pain did you have in the last
Table 4 shows that many respondents had multiple medications
ordered by multiple routes. This may have influenced patients’
ability to name their medications. Only twenty-six (38%) of those
surveyed could name one of the medications they were taking for
pain. Eleven respondents (16%) could name two or more medica
tions, however, the remaining patients stated that they could not
name their pain medicines.
The responses to the experience and knowledge questions are of
interest when coupled with the barriers to pain control that patients
themselves identified (Figure 7). While it seems understood that
insurance will cover all or most of the costs of hospitalization, it is
obvious that patients were also thinking about barriers outside of the
acute care setting, where outpatient medications, Patient Controlled
Analgesia (PCA) or other therapies are not wholly or partially
covered by insurance.
Patients also indicated that they use many alternatives to pharma
ceutical pain control methods. Figure 8 illustrates that over half
(53%) of those surveyed consider prayer an alternative therapy,
while Healing Touch, relaxation, heat and imagery were used as
well. One patient stated that he used marijuana and beer, another
indicated that music helped and a third indicated that concurrent
chemotherapy had relieved some of his pain. Thirty-seven respon
dents (55%) of those surveyed indicated that they would be willing
to use alternatives, twenty-two (32%) respondents indicated they
were undecided while only four (5.9%) stated “no”to this option.
When asked to identify health care team members, other than their
physician or primary nurse, whom they felt were helpful in control
ling their pain, 41% of those surveyed responded “none”. Respon
dents from institutions with formal pain teams indicated that those
teams had been helpful as indicated in Figure 9. Patients listed
family, self, and friends in the “Other” category.
A nonparametric measure of association between variables, the
Spearman rank-order correlation coefficients were computed for the
experience (pain and side effect) questions and the knowledge
statements. In general, there were significant positive correlations
between some of the questions within each group. Only the state
ment “Cancer pain can be relieved” showed a significant positive
correlation with patients’ satisfaction with their current pain man
agement (r=O.55, p<.OO1). There was a small but significant nega
tive correlation between the amount ofpain patients were experienc
ing at the time the survey and their satisfaction. (r=O.29, p=O.O2).
A mean pain experience score was computed for each patient
summing the responses to the questions “How much pain do you
have right now?,”” How much pain have you had over the last
week?” and dividing by 3. Similarly a mean knowledge score was
computed by dividing the sum of the responses to the knowledge
questions by 4. There was a small, significant, negative Spearman
correlation between the mean pain score and satisfaction (r=O.34.
p=O.OO7) but no significant correlations between mean knowledge
score and satisfaction or between the mean knowledge and experi
ence scores.
Respondents were divided into two groups: those who indicated
fear of addiction as a barrier to pain management and those who did
not. The responses of the two groups were compared for knowledge,
experience and satisfaction. The group that did not identify addic
tion as a barrier had a higher mean level of agreement with the
knowledge questions than those who did. There was also a signifi
cant difference in satisfaction with pain management between the
two groups (x2=l5.13, df=9, p=O.O4O). The difference between the
mean responses to the experience questions was small. The non-
parametric Mann-Whitney U (Wilcoxon Rank-Sum) test, which
may be used to test whether two independent samples are drawn
from the same population, was performed on the mean experience
and knowledge scores of the two groups. A significant difference
was found between the mean knowledge score of the two groups
(U=2 10.5, p=O.002), but no statistically significant difference was
found between the mean experience scores (U=436.5, p=O.’71 ). This
is consistent with the results of the analysis of the individual
knowledge and experience questions.
Findings: Institutional Audit
Four of the institutions participating in the survey completed the
institutional audit form, which identified the presence or absence of
processes that support effective pain management. Of the four
participating institutions, two have a formal pain team in place. All
of the responding institutions have admission forms that screen for
pain and all have a flow sheet of some kind forpain, although in one
instance it is only if a patient is on a PCA. All of the hospitals have
equianalgesic charts or other tools available for staff to use. None
use caremaps or critical paths nor do they have a specific mechanism
to signal ongoing or severe pain, such as incident reports.
Two of the four medical centers require new staff to have or to
learn basic pain management principles as part of orientation. The
two institutions with formalized pain management teams offer
formal educational programs to patients and families and the oppor
tunity for a formal interdisciplinary pain consultation. These insti
tutions incorporate some assessment of patient satisfaction into
continuous quality improvement methods. However, the policies
that would trigger some type ofprofessional response for unrelieved
pain focuses only on patients using PCAs or other invasive tech
niques, not patients using oral analgesics or other modalities.
Two of the institutions stated that they were involved in ongoing
research with regard to pain (not including this study), that costs are
an important part of this research and that they have a hotline or
consultation service available to outside resources.
Discussion and Recommendations
There were many reasons for conducting this multi-site investiga
tion. Most cancer patients in Hawaii receive their primary and
secondary care on Oahu where they may access a variety ofdifferent
Number of patients on one opioid 8
Number of patients on PCA 18
Number of patients with parenteral analgesics
and oral opioidsladjuvants ordered 22
Number of patients with more than three routes
ordered (IM, oral, transdermal, rectal, IV) 42
Number of patients with more than three
medications from the same class ordered 17
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agencies depending on physician privileges, bed availability and
services needed. To date, there has been no aggregate data available
to use to evaluate cancer pain management in Hawaii. This study is
a starting point for assessing whether professional guidelines re
garding pain and its management are being translated into practice.
As the chart review and institutional audit show, prescriptive
practices, assessment and documentation vary between settings and
practitioners. This is reflected in the fact that patients are not able to
identify health care team members other than their physician and
nurse as helpful with pain, except where a pain team was available.
The majority of those surveyed were also unable to name the
medications they were taking for pain. This may have been a
phenomena ofadmission to a facility, where one expects profession
als to take the responsibility for the knowledge and management of
one’s needs. However, the AHCPR and APS guidelines recommend
that responsibility for pain management be assigned to “clinicians
most knowledgeable, experienced, interested and able to respond to
patients’ needs in a timely fashion.”26 The AHCPR and APS
guidelines also state that patients be informed of the importance of
their pain management, participate in their pain management plan of
care and that pain be addressed in a collaborative and interdiscipli
nary manner. Therefore, a strong recommendation is made that
institutions designate a person or team that will be responsible for
educating patients and staff, as well as designing and evaluating
programs that will ensure optimal pain management.
The findings of this study indicate that use of current cancer pain
guidelines is inconsistent, as the data shows that patients had orders
for multiple opioids and adjuvants in insufficient quantities or by
multiple routes. Many participants had multiple medications pre
scribed from the same “step” of the WHO Analgesic Ladder, i.e.,
fentanyl patches, PCA and oral morphine. This may be a reflection
of inconsistent assessment and feedback or that practitioners are
hesitant to order opioids in a large enough dose to control pain.
However, it may also be that multiple modalities, including radia
tion and chemotherapy, were necessary to control cancer pain,
which by its evolving nature presents a challenge.
This may account for the fact that one-fourth of the patients
surveyed were on IV PCA, one was on subcutaneous PCA and one
on intrathecal morphine. This is an interesting finding when one
considers that 90% of all patients surveyed were also on oral
medications. While it is difficult to quantify the benefit of any given
pain control regimen compared with pain relief, all of the current
guidelines suggest using the oral route whenever possible with the
subcutaneous route as the next alternative. Hospices have used this
concept for years in the home setting, with 90% of all patients
maintained on oral medications with a high degree of relief and
satisfaction. 6.17 It may be that PCA was being used to determine the
appropriate oral dose or patients were being weaned off PCA to
other routes. The data is insufficient to determine the reasons for
using PCA, however, one questions whether the use of PCA in the
hospital was necessary in every case.
Only two of the respondents were admitted solely for pain control
so respondents’ reports of severe pain in the week prior to the survey
leads to many questions. Although 57% of those surveyed experi
enced pain beginning one to twelve months prior to the survey, the
scope of this study could not examine how their pain was being
managed during that time. One can only assume that there may be
inconsistencies betwen outpatient and inpatient pain management
related to many variables, including access to services, such as home
care or hospice, or reimbursement issues. Further studies are needed
in Hawaii to determine how pain is being managed in the outpatient
setting. The survey results do indicate that patients are concerned
about costs, addiction and side effects and having enough medica
tions “for later” should their pain become worse. The costs of pain
management can be quite high, so respondents’ anxiety about cost
is appropriate, especially for patients on fixed incomes or whose
illness may result in a loss of employee health insurance due to an
inability to work. A patient in the hospital may have insurance
coverage for multiple medications but if these same medications are
prescribed on discharge, even the wholesale cost (without a phar
macy markup) can be prohibitive. The major determinants in pre
scribing pain medicines are a patient’s condition, disease status, past
pain/drug history, side effects and current response. If there is no
physiologic basis for prescribing one drug over another, then costs,
availability, cultural biases and other factors should be considered.
Professional and community education is needed to extinguish fears
of addiction and to increase knowledge about the variety of pain
management routes, medications and resources that are available.
The use ofPCA and the high incidence ofpolypharmacy may have
influenced patients’ responses to the statement “Cancer pain can be
relieved.” The responses indicate that although pain management
experts believe cancer pain can be relieved, this belief is not shared
by all of the respondents in this study. The AHCPR and APS
guidelines propose that pain be assessed individually, with “relief’
defined by the patient’s ability to function, sleep, work and other
wise continue their activities of daily living. In other words, achiev
ing a pain rating of “0” may not be the primary goal. One questions
whether the inconsistent use of guidelines and apparent lack of
participation by patients influenced their responses. Standardizing
assessment tools and practices and using easily understood algo
rithms for prescribing would help clinicians and patients manage
pain more effectively.
Anxiety about costs, fear of addiction and undesirable opiate side
effects may also influence the responses that show many patients
would opt to use alternatives. A mainland study showed patients
made “425 million visits to unconventional providers compared
with 338 million visits to primary care physicians.”21 In Hawaii,
there are many cultural practices that professionals view as ques
tionable alternatives to Western medicine but that patients consider
acceptable. Of interest is the finding that respondents consider
prayer an alternative therapy. The impact of spirituality on pain and
the use of nondrug interventions would make an interesting subject
for further research, particularly in a multi-cultural environment.
The use of cold, heat, relaxation, imagery, Healing Touch, distrac
tion and massage may be widespread because they incorporate the
“human touch” that contributes to patient satisfaction. Many of
these therapies are free or cost no more than $25, making them cost-
effective and attractive to patients. More studies are needed to
determine how these therapies can be incorporated into existing
health care delivery systems and their impact on the overall cost of
pain management.
The factor that was most often identified as interfering with pain
control was “having to wait too long for medications.” This first
relates directly to nursing practices as well as patient education.
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Figure 5.—Patients’ Pain Experience at Time of Survey
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Figure 2.—Respondents by Diagnosis
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While patients remain on PRN medications, they will
still have to ask for their medications. They may also
be reluctant to “bother the nurse” or may be unedu
cated about the need to ask for medication before the
pain escalates. This complaint may also be the reason
for the use of a PCA pump. One study affirms that the
average time it takes for a nurse to deliver an analge
sic, including documentation, is 18.42 minutes while
others show a waiting time of up to 30 minutes.8This
may be due to variables such as staffing shortages that
mean a patient’s call light is not answered in a timely
manner. While this seems to be a minor problem, it
does show that ongoing institutional and professional assessment is necessary to
define a standard of practice with regard to pain management.
It appears that some of the guidelines are used part of the time in various ways.
While this study cannot show the reasons for inconsistent use of the guidelines, the
data does support the fact that there needs to be standardization and further research
in a number of areas. The Hawaii Cancer Pain Initiative strongly recommends
devising a standardized pain assessment tool and flow sheet that will be used by
all medical centers and outpatient agencies. Adopting algorithms that utilize
methods of determining efficacy and cost-effectiveness for use when prescribing
medications should be considered for use along with the WHO analgesic ladder.
All institutions providing inpatient care to cancer patients should have a pain
management team or service. If this is outside the resource capability of the agency,
then a mechanism for referring to or accessing a pain management resource should
be defined. Basic pain management education should be required for graduation
from Hawaii’s nursing and medical schools. Acute medical centers providing care
to oncology patients should mandate competency in cancer pain management for
all clinicians working in this area. Recognizing that patients themselves often
present many barriers to pain control, research into the educational needs of the
Island’s various cultural groups, especially validating the use of pain rating tools
in other languages, may define culture-specific barriers to pain management. A
study comparing outpatient pain management to this inpatient study is needed to
provide important information about the needs of cancer patients across the
continuum of care. As with any endeavor, these recommendations will require
ongoing energy, interaction and commitment from individuals and institutions
alike but the benefit to our Island community will be worth the effort.
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